Abstract
The hepatitis C virus (HCV) is a single-stranded enveloped RNA virus, belonging to the Hepacivirus genus within the Flaviviridae family. HCV infection has become a major worldwide health problem because it causes a chronic hepatitis leading to hepatocarcinoma (HCC) and to non-Hodgkins B-cell lymphoma (NHL). The absence of a reliable experimental model, which mimics the physiological effect of HCV infection in human subjects, hampered the analysis of the mechanisms by which HCV leads to cancer. Nevertheless, both in vitro expression systems and in vivo transgenic mice studies suggest that HCV persistent infection in the host is able to induce neoplastic transformation. The oncogenic properties of HCV are often related to the ability of HCV-encoded proteins to interfere with cell signaling through the interaction with different molecules involved in the control of cell proliferation, apoptosis and interferon (IFN)-signaling pathways. The present systematic review will mainly focus on the HCV proteins dependent pathogenetic effects on the most important regulatory proteins of cell homeostasis. Since poor efficacy of the current therapy, studying the mechanisms underlying HCV-induced cell transformation and immune evasion will help researchers to identify new therapeutic targets, which may be useful in the near future to develop more effective and better-tolerated therapies, capable of impairing or reversing the progression of HCV-related tumors.
Keywords: HCV, HCC, HCV-related NHL, IFN, treatment, gene therapy
Current Cancer Therapy Reviews
Title: HCV-Related Transformation and New Therapeutic Strategies: An Update
Volume: 2 Issue: 1
Author(s): Clara Balsano and Anna Alisi
Affiliation:
Keywords: HCV, HCC, HCV-related NHL, IFN, treatment, gene therapy
Abstract: The hepatitis C virus (HCV) is a single-stranded enveloped RNA virus, belonging to the Hepacivirus genus within the Flaviviridae family. HCV infection has become a major worldwide health problem because it causes a chronic hepatitis leading to hepatocarcinoma (HCC) and to non-Hodgkins B-cell lymphoma (NHL). The absence of a reliable experimental model, which mimics the physiological effect of HCV infection in human subjects, hampered the analysis of the mechanisms by which HCV leads to cancer. Nevertheless, both in vitro expression systems and in vivo transgenic mice studies suggest that HCV persistent infection in the host is able to induce neoplastic transformation. The oncogenic properties of HCV are often related to the ability of HCV-encoded proteins to interfere with cell signaling through the interaction with different molecules involved in the control of cell proliferation, apoptosis and interferon (IFN)-signaling pathways. The present systematic review will mainly focus on the HCV proteins dependent pathogenetic effects on the most important regulatory proteins of cell homeostasis. Since poor efficacy of the current therapy, studying the mechanisms underlying HCV-induced cell transformation and immune evasion will help researchers to identify new therapeutic targets, which may be useful in the near future to develop more effective and better-tolerated therapies, capable of impairing or reversing the progression of HCV-related tumors.
Export Options
About this article
Cite this article as:
Balsano Clara and Alisi Anna, HCV-Related Transformation and New Therapeutic Strategies: An Update, Current Cancer Therapy Reviews 2006; 2 (1) . https://dx.doi.org/10.2174/157339406775471830
DOI https://dx.doi.org/10.2174/157339406775471830 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Antibodies in HIV Treatment - Classical Approaches to Novel Advances
Current Pharmaceutical Design Current and Potential Anticancer Drugs Targeting Members of the UHRF1 Complex Including Epigenetic Modifiers
Recent Patents on Anti-Cancer Drug Discovery Genetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma
Current Genomics Roles of Natural Compounds from Medicinal Plants in Cancer Treatment: Structure and Mode of Action at Molecular Level
Medicinal Chemistry DNA Repair in Normal and Cancer Stem Cells, with Special Reference to the Central Nervous System
Current Medicinal Chemistry Luteolin Stimulates Proliferation and Inhibits Late Differentiation of Primary Rat Calvarial Osteoblast Induced by High-dose Dexamethasone via Sema3A /NRP1/Pleixin A1
Current Pharmaceutical Biotechnology Targeting Glioblastoma: The Current State of Different Therapeutic Approaches
Current Neuropharmacology Pharmacogenomics of Human ABC Transporters: Detection of Clinically Important SNPs by SmartAmp2 Method
Current Pharmaceutical Biotechnology Animal Models for the Evaluation of Theranostic Radiopharmaceuticals
Current Radiopharmaceuticals Biological Effects of Curcumin and Its Role in Cancer Chemoprevention and Therapy
Anti-Cancer Agents in Medicinal Chemistry Subject index to volume 3
Current Molecular Medicine Cornea: Window to Ocular Immunology
Current Immunology Reviews (Discontinued) Weight Optimized Neural Network Using Metaheuristics for the Classification of Large Cell Carcinoma and Adenocarcinoma from Lung Imaging
Current Signal Transduction Therapy Targeting Small Molecule Tyrosine Kinases by Polyphenols: New Move Towards Anti-tumor Drug Discovery
Current Drug Discovery Technologies Recent Progress on Chemical Biology of Pluripotent Stem Cell Selfrenewal, Reprogramming and Cardiomyogenesis
Recent Patents on Regenerative Medicine Kinetic Evaluation of Anti-tumor Chlorambucil Release from O-stearoyl Mannose PLGA Nanoparticles
Current Nanomedicine Stem Cells, Cancer, Liver, and Liver Cancer Stem Cells: Finding a Way Out of the Labyrinth...
Current Cancer Drug Targets The Prognosis and Treatment of Adult Acute Leukemia with 11q23/MLL According to the Fusion Partner
Current Cancer Therapy Reviews Mevalonate-Ras Homology (Rho)/Rho-Associated Coiled-Coil-Forming Protein Kinase (ROCK)-Mediated Signaling Pathway as a Therapeutic Target for the Treatment of Endometriosis-Associated Fibrosis
Current Signal Transduction Therapy Marine Bromopyrrole Alkaloids: Synthesis and Diverse Medicinal Applications
Current Topics in Medicinal Chemistry